Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathway

Teresa Campbell, Jesse Slone, Jimmy Vu, Wensheng Liu, Li Yang, Adam Dourson, Luis F Queme, Michael P Jankowski, Taosheng Huang · 2025

Read Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathway by Teresa Campbell, Jesse Slone, Jimmy Vu, Wensheng Liu, Li Yang, Adam Dourson, Luis F Queme, Michael P Jankowski, Taosheng Huang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12727864.txt.

Description

Campbell and co-authors find in 2025 a new disease path for a rare mitochondrial illness tied to faults in a gene called FDXR. The gene's loss causes abnormal iron build up in mitochondria, but the chain of harm was unclear. They built a mouse model of the human hotspot variant.

Fat damage rose in inner mitochondrial and outer cell membranes, which made cells prone to an iron driven death called ferroptosis. A defense pathway and its target gene were disrupted in the model. A drug that switches that pathway on, already approved for another disease, eased the harm. The authors propose it as a near term treatment option.

Catalog record

CREATORTeresa Campbell, Jesse Slone, Jimmy Vu, Wensheng Liu, Li Yang, Adam Dourson, Luis F Queme, Michael P Jankowski, Taosheng Huang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12727864

Browse the full library · About the Tower of Babel